TY - JOUR
T1 - The Therapeutic Target Database
T2 - An Internet resource for the primary targets of approved, clinical trial and experimental drugs
AU - Liu, Xin
AU - Zhu, Feng
AU - Ma, Xiaohua
AU - Tao, Lin
AU - Zhang, Jingxian
AU - Yang, Shengyong
AU - Wei, Yuquan
AU - Chen, Yu Zong
PY - 2011/8
Y1 - 2011/8
N2 - Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets. A challenge in drug discovery is to decide which targets to pursue from an increasing pool of potential targets, given the fact that few innovative targets have made it to the approval list each year. Knowledge of existing drug targets (both approved and within clinical trials) is highly useful for facilitating target discovery, selection, exploration and tool development. The Therapeutic Target Database (TTD) has been developed and updated to provide information on 358 successful targets, 251 clinical trial targets and 1254 research targets in addition to 1511 approved drugs, 1118 clinical trials drugs and 2331 experimental drugs linked to their primary targets (3257 drugs with available structure data). This review briefly describes the TTD database and illustrates how its data can be explored for facilitating target and drug searches, the study of the mechanism of multi-target drugs and the development of in silico target discovery tools.
AB - Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets. A challenge in drug discovery is to decide which targets to pursue from an increasing pool of potential targets, given the fact that few innovative targets have made it to the approval list each year. Knowledge of existing drug targets (both approved and within clinical trials) is highly useful for facilitating target discovery, selection, exploration and tool development. The Therapeutic Target Database (TTD) has been developed and updated to provide information on 358 successful targets, 251 clinical trial targets and 1254 research targets in addition to 1511 approved drugs, 1118 clinical trials drugs and 2331 experimental drugs linked to their primary targets (3257 drugs with available structure data). This review briefly describes the TTD database and illustrates how its data can be explored for facilitating target and drug searches, the study of the mechanism of multi-target drugs and the development of in silico target discovery tools.
KW - Multi-target drugs
KW - Primary target
KW - TTD
KW - in silico target discovery
UR - http://www.scopus.com/inward/record.url?scp=79960254626&partnerID=8YFLogxK
U2 - 10.1517/14728222.2011.586635
DO - 10.1517/14728222.2011.586635
M3 - Review article
C2 - 21619487
AN - SCOPUS:79960254626
SN - 1472-8222
VL - 15
SP - 903
EP - 912
JO - Expert Opinion on Therapeutic Targets
JF - Expert Opinion on Therapeutic Targets
IS - 8
ER -